p53: a target for new anticancer drugs or a target for old drugs?
Brown
R
R
CRC Dept of Medical Oncology, Beatson Laboratories, Glasgow, UK.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D004249:DNA Damage / Q000187:drug effects; D016158:Genes, p53 / Q000187:drug effects*; D006801:Humans; D009154:Mutation; D016159:Tumor Suppressor Protein p53 / Q000187:drug effects / Q000235:genetics / Q000502:physiology
D000970:Antineoplastic Agents; D016159:Tumor Suppressor Protein p53